We are live on ! Find out more
AXNX

Axonics, Inc. Common Stock

Delisted

AXNX was delisted on the 14th of November, 2024.

103 hedge funds and large institutions have $565M invested in Axonics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 42 increasing their positions, 10 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 10

203% more call options, than puts

Call options by funds: $3.38M | Put options by funds: $1.11M

147% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 15

116% more capital invested

Capital invested by funds: $261M → $565M (+$304M)

27% more funds holding

Funds holding: 81103 (+22)

Holders
103
Holders Change
+22
Holders Change %
+27.16%
% of All Funds
2.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
37
Increased
42
Reduced
10
Closed
15
Calls
$3.38M
Puts
$1.11M
Net Calls
+$2.26M
Net Calls Change
+$2.26M
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$5.6M +$344K +14,405 +8%
KCM
27
Kennedy Capital Management
Missouri
$5.2M +$4.48M +187,523 New
AAP
28
Ardsley Advisory Partners
Connecticut
$5M +$4.31M +180,500 New
PHP
29
Parkman Healthcare Partners
Connecticut
$4.61M +$3.97M +166,231 New
PVI
30
Pura Vida Investments
New York
$4.53M +$3.9M +163,490 New
MS
31
Maven Securities
Jersey
$4.33M +$3.84M +161,000 New
Allianz Asset Management
32
Allianz Asset Management
Germany
$4.3M +$3.7M +155,214 New
Bank of America
33
Bank of America
North Carolina
$3.98M +$2.78M +116,284 +425%
Goldman Sachs
34
Goldman Sachs
New York
$3.82M +$2.84M +118,966 +631%
N
35
Nuveen
North Carolina
$3.4M +$1.41M +59,140 +93%
MF
36
Magnetar Financial
Illinois
$3M -$627K -26,253 -19%
CAM
37
Crown Advisors Management
California
$2.77M +$2.39M +100,000 New
SSA
38
Schonfeld Strategic Advisors
New York
$2.76M +$1.26M +52,600 +112%
Charles Schwab
39
Charles Schwab
California
$2.63M +$608K +25,490 +37%
Morgan Stanley
40
Morgan Stanley
New York
$2.24M +$723K +30,312 +60%
PCM
41
Pinz Capital Management
New York
$2.1M +$1.81M +75,800 New
Bank of New York Mellon
42
Bank of New York Mellon
New York
$1.81M -$239K -10,022 -13%
Macquarie Group
43
Macquarie Group
Australia
$1.75M +$1.51M +63,111 New
Neuberger Berman Group
44
Neuberger Berman Group
New York
$1.67M +$1.44M +60,200 New
PA
45
Perceptive Advisors
New York
$1.52M +$1.31M +55,000 New
LCM
46
Laurion Capital Management
New York
$1.39M +$1.19M +50,000 New
Wells Fargo
47
Wells Fargo
California
$1.33M +$133K +5,561 +13%
CSS
48
Cubist Systematic Strategies
Connecticut
$1.13M +$971K +40,700 New
Swiss National Bank
49
Swiss National Bank
Switzerland
$881K +$315K +13,200 +71%
Squarepoint
50
Squarepoint
New York
$855K +$196K +8,192 +36%

AXNX Hedge Fund Activity: Q4 2019 in Review

103 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q4 2019, worth a combined $565M — up 116% from $261M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new AXNX positions and 15 closed out — a net gain of 22 holders — while 42 added to existing stakes and 10 trimmed.

The largest buyer was Millennium Management, adding an estimated $40.2M. The largest seller was Fidelity Investments, cutting an estimated $9.29M.

  • 103 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q4 2019, up from 81 in Q3 2019.
  • Funds reported $565M of Axonics, Inc. Common Stock stock for Q4 2019, up 116% quarter-over-quarter.
  • 37 funds opened new Axonics, Inc. Common Stock positions in Q4 2019 and 15 closed out, a net change of +22 holders.
  • The largest Axonics, Inc. Common Stock buyer in Q4 2019 was Millennium Management, an estimated $40.2M added.
  • The largest Axonics, Inc. Common Stock seller in Q4 2019 was Fidelity Investments, an estimated $9.29M sold.

Based on aggregated 13F filings for Q4 2019.